Contra-indicated in patients with active pathological bleeding, prior transient ischemic attack or stroke.
- TRADE NAME: Effient (Lilly)
- INDICATIONS: Acute coronary syndrome in patients who are to be managed with percutaneous coronary intervention
- CLASS: Antiplatelet; thienopyridine
- HALF-LIFE: 2–15 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Cangrelor, Clopidogrel, Conivaptan, Coumarins, Darunavir, Delavirdine, Diclofenac, Indinavir, Inotersen, Meloxicam, NSAIDs, Phenindione, Telithromycin, Voriconazole, Warfarin
BLEEDING RISK
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
